Literature DB >> 1565114

Evaluation of phrenic nerve and pulmonary function in hereditary motor and sensory neuropathy, type I.

G T Carter1, D D Kilmer, H W Bonekat, J S Lieberman, W M Fowler.   

Abstract

Phrenic nerve and diaphragmatic dysfunction has been assumed to be the cause of respiratory failure in hereditary motor and sensory neuropathy, type 1 (HMSN I). In order to determine the relationship between phrenic nerve and pulmonary function in this disease, 25 patients underwent a 4-step evaluation process consisting of: (1) bilateral phrenic nerve conduction study; (2) median, peroneal, and tibial motor conduction studies; (3) measurement of forced vital capacity (FVC) and maximal inspiratory and expiratory pressures (MIP, MEP); and (4) pulmonary-focused history and physical. Phrenic nerve motor latency was abnormally prolonged in 22 of the 23 (96%) subjects when a response was obtained. All had slowed velocity or absent peripheral motor conduction responses. Vital capacity was abnormally reduced in 6 of the 25 (24%) subjects. Eight (32%) had an abnormally reduced MIP, while 19 (76%) had an abnormally reduced MEP. Only 2 (8%) subjects had clinical evidence of pulmonary dysfunction. None of the dependent variables (FVC, MIP, MEP, peripheral nerve conduction, or clinical examination) correlated with phrenic nerve latencies. Although phrenic nerve latencies are markedly prolonged in HMSN I, these values are not useful in predicting respiratory dysfunction.

Entities:  

Mesh:

Year:  1992        PMID: 1565114     DOI: 10.1002/mus.880150407

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  6 in total

1.  Subclinical electrophysiological alterations of phrenic nerve in chronic inflammatory demyelinating polyneuropathy.

Authors:  Dario Cocito; Palma Ciaramitaro; Eugenia Rota; Gianluca Isoardo; Silvana Cannizzo; Fabio Poglio; Alessia Tavella; Lorys Castelli; Ilaria Paolasso; Bruno Bergamasco; Sergio Baldi
Journal:  J Neurol       Date:  2005-03-21       Impact factor: 4.849

Review 2.  Disorders of pulmonary function, sleep, and the upper airway in Charcot-Marie-Tooth disease.

Authors:  Loutfi S Aboussouan; Richard A Lewis; Michael E Shy
Journal:  Lung       Date:  2007-02-09       Impact factor: 2.584

3.  Respiratory dysfunction in Charcot-Marie-Tooth disease type 1A.

Authors:  Mônica de Carvalho Alcântara; Marcello H Nogueira-Barbosa; Regina Maria França Fernandes; Geruza Alves da Silva; Charles Marques Lourenço; Heide H Sander; Wilson Marques Junior
Journal:  J Neurol       Date:  2015-03-13       Impact factor: 4.849

4.  Phrenic neuropathy in chronic renal failure.

Authors:  U Zifko; M Auinger; G Albrecht; T Kästenbauer; H Lahrmann; W Grisold; T Wanke
Journal:  Thorax       Date:  1995-07       Impact factor: 9.139

5.  Charcot-Marie-Tooth disease.

Authors:  Gregory T Carter; Michael D Weiss; Jay J Han; Phillip F Chance; John D England
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

6.  Pain in youths with neuromuscular disease.

Authors:  Joyce M Engel; Deborah Kartin; Gregory T Carter; Mark P Jensen; Kenneth M Jaffe
Journal:  Am J Hosp Palliat Care       Date:  2009 Oct-Nov       Impact factor: 2.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.